Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Business

CVS Health to no longer sell decongestants with phenylephrine

by October 22, 2023
October 22, 2023
CVS Health to no longer sell decongestants with phenylephrine

U.S. pharmacy chain CVS Health said on Thursday it is pulling some of the most common decongestants with phenylephrine as the only active ingredient from its shelves and will no longer sell them.

The move comes after a panel of advisers to U.S. health regulators raised doubts over the efficacy of the ingredient.

Last month, the panel refused to back the effectiveness of oral over-the-counter medicines made with phenylephrine, adding that no more trials were required to prove otherwise.

CVS said “other oral cough and cold products will continue to be offered to meet consumer needs.”

Phenylephrine was substituted for pseudoephedrine in many non-prescription cold and allergy medicines after the latter was restricted amid reports of abuse.

Phenylephrine is a major component used in some of popular products like Benadryl, Sudafed, GSK’s Advil and Kenvue’s Tylenol.

This post appeared first on NBC NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Abortion bans and anti-LGBTQ laws are complicating business travel
next post
China adopted ‘more dangerous’ tactics in 2022 as ‘only competitor’ to US, Pentagon warns in new report

Related Posts

Honda recalls more than 2.5 million cars over...

December 23, 2023

Truck purchases are driving up the average cost...

August 24, 2023

Ticketmaster’s hidden fees remain common long after it...

October 26, 2023

Honda recalls 1.2 million U.S. vehicles for rear...

June 24, 2023

Russian oligarch’s yacht is costing U.S. taxpayers close...

March 7, 2024

Rite Aid bankruptcy means pharmacies will keep dwindling

October 17, 2023

Supreme Court Justice Samuel Alito sold Bud Light...

May 22, 2024

Walmart to pay $10 million to settle lawsuit...

June 24, 2025

Meta approves plan for bigger executive bonuses following...

February 22, 2025

Free cash programs spread as more cities expand...

April 14, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    • Asra Minerals

    • Element79 Gold Corp Announces Corporate Update and Strategic Leadership Changes With Focus On Accelerating Nevada Asset Development

    • OPINION — Goldenomics 103: Gold Protects and Performs

    • Editor’s Picks: Gold Tariff Threat Ends, Price Reacts to Fresh Inflation Data

    • Top 5 Canadian Mining Stocks This Week: Focus Graphite Rises Over 90 Percent

    Categories

    • Business (1,335)
    • Investing (2,785)
    • Politics (3,699)
    • Stocks (1,760)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 moneycontrolplace.com | All Rights Reserved